BRD4 and non-small cell lung carcinoma: Similarly, patients with NSCLC having relatively lower BRD4 or PCAF expression had a significantly longer survival time than that in patients with NSCLC having relatively higher expression after pulmonary resection (Figs 7H and EV3F).